• 60 Citations
  • 4 h-Index
20132018
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Robin Gasiorowski completed medical training at Cambridge University and University College London, before moving to Australia in 2004. Following specialist haematology training at Royal Prince Alfred and Concord hospitals he now works as a clinical and laboratory haematologist, with appointments at Concord and Macquarie University Hospitals. He has a particular interest in acute leukaemia and high-grade lymphoma and in 2017 completed his PhD with the Dendritic Cell Research group at the University of Sydney, developing novel therapeutic antibodies for the treatment of Acute Myeloid Leukaemia (AML). Whilst he continues to be contribute to this group’s work, he also has a strong interest in clinical research, particularly in the development of novel immune therapies for patients with haematological malignancies. He has been a principal investigator on a number of industry and ALLG sponsored clinical trials for patients with high grade lymphoma and leukaemia.

Education/Academic qualification

Medicine, PhD, University of Sydney

MA (Cantab)

MBBS

FRACP

FRCPA

External positions

Senior Lecturer, University of Sydney

2015 → …

Staff Specialist in Haematology, Concord Repatriation General Hospital

2014 → …

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Dendritic Cells Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Peer Review Medicine & Life Sciences
Evidence-Based Practice Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Hematologic Neoplasms Medicine & Life Sciences
Blood Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2018

  • 60 Citations
  • 4 h-Index
  • 7 Meeting abstract
  • 6 Article
  • 2 Review article

A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission

Hsu, J. L., Bryant, C. E., Papadimitrious, M. S., Kong, B., Gasiorowski, R. E., Orellana, D., McGuire, H. M., Fazekas de St Groth, B., Joshua, D. E., Ho, P. J., Larsen, S., Iland, H. J., Gibson, J., Clark, G. J., Fromm, P. D. & Hart, D. N. J., 3 Apr 2018, In : OncoImmunology. 7, 4, p. 1-11 11 p., e1419114.

Research output: Contribution to journalArticleResearchpeer-review

Acute Myeloid Leukemia
Dendritic Cells
Blood Cells
Vaccines
T-Lymphocytes

A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission

Fromm, P., Hsu, J., Bryant, C., Papadimitrious, M., Kong, B., Gasiorowski, R., Orellana, D., McGuire, H., de St Groth, B., Joshua, D., Ho, P. J., Larsen, S., Iland, H., Gibson, J., Clark, G. & Hart, D., 1 May 2018, In : European Journal of Immunology. 48, Suppl. 1, p. 74-75 2 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for waldenström macroglobulinemia

Othman, J., Verner, E., Tam, C. S., Huang, J., Lin, L., Hilger, J., Trotman, J. & Gasiorowski, R., 2018, In : Haematologica. 103, 5, p. e223-e225 3 p.

Research output: Contribution to journalArticleResearchpeer-review

A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission

Hart, D. N. J., Hsu, J. L., Bryant, C. E., Papadimitrious, M. S., Kong, B., Gasiorowski, R. E., Orellana, D. W., McGuire, H. M., Fazekas de St Groth, B., Joshua, D. E., Ho, P. J., Larsen, S. R., Iland, H. J., Gibson, J., Clark, G. J. & Fromm, P. D., 7 Dec 2017, In : 56th ASH Annual Meeting and Exposition : abstracts and program. 130, Suppl 1, p. 2648 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Autoimmune hemolytic anemia and hemolytic transfusion reactions in two patients with Waldenstrom macroglobulinemia treated with combination BTK inhibitor and PD-1 inhibitor

Othman, J., Verner, E., Tam, C. S., Huang, J., Lin, L., Hilger, J., Trotman, J. & Gasiorowski, R. E., 7 Dec 2017, In : Blood. 130, Suppl 1, p. 5153 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Activities 2018 2018

Macquarie University Human Research Ethics Committee

Robin Gasiorowski (Participant)
Jan 2018 → …

Activity: Other